Genus Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-4,795
Closed -$1.5M 193
2024
Q2
$1.5M Buy
+4,795
New +$1.41M 0.2% 120
2024
Q1
Sell
-20,395
Closed -$5.87M 208
2023
Q4
$5.87M Buy
+20,395
New +$5.56M 0.86% 37

Other funds holding AMGN

Genus Capital Management's AMGN Position: Q2 2026 in Review

Genus Capital Management reduced its Amgen (AMGN) stake by 18% in Q2 2026, selling an estimated $2.8M and leaving 36,237 shares worth $13.1M. The position accounts for 1.29% of the portfolio, ranked #21.

Genus Capital Management first reported a position in AMGN in Q2 2023 and has held it in 8 quarters since. The position peaked at $15.6M in Q1 2026. 3,160 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Genus Capital Management held 36,237 shares of Amgen worth $13.1M as of Q2 2026.
  • Genus Capital Management sold 8,190 Amgen shares in Q2 2026, an estimated $2.8M.
  • Amgen made up 1.29% of Genus Capital Management's portfolio in Q2 2026, its #21 holding.
  • Genus Capital Management first reported a position in Amgen in Q2 2023 and has held it in 8 quarters since.
  • Genus Capital Management's Amgen position peaked at $15.6M in Q1 2026.
  • 3,160 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Genus Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.